v3.25.4
FAIR VALUE MEASUREMENTS (Tables)
12 Months Ended
Dec. 31, 2025
Fair Value Disclosures [Abstract]  
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis
The following tables present information by year about the Company’s financial instruments that are measured at fair value on a recurring basis, by level, within the fair value hierarchy:
As of December 31, 2025
($ in thousands)
TotalQuoted Prices in Active MarketSignificant Other Observable InputsSignificant Other Unobservable Inputs
(Level 1)(Level 2)(Level 3)
Liabilities:
Derivative warrant liabilities - Public517 517 — — 
Derivative warrant liabilities - Private664 — 664 — 
Contingent consideration liabilities
21,020 — — 21,020 
Embedded derivatives
11,833 — — 11,833 
As of December 31, 2024
($ in thousands)
TotalQuoted Prices in Active MarketSignificant Other Observable InputsSignificant Other Unobservable Inputs
(Level 1)(Level 2)(Level 3)
Liabilities:
Derivative warrant liabilities - Public1,983 1,983 — — 
Derivative warrant liabilities - Private3,038 — 3,038 — 
Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
The following tables summarize the change of all liabilities measured at estimated fair value on a recurring basis using significant unobservable inputs (Level 3):
(In thousands)
Contingent Consideration
Embedded Derivatives
Liabilities:
Balance at January 1, 2025
$— $— 
Additions
21,881 12,553 
Settlements
— (864)
Change in fair value
(861)144 
Balance at December 31, 2025
$21,020 $11,833 
Schedule of Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation
The following tables summarize the change of all liabilities measured at estimated fair value on a recurring basis using significant unobservable inputs (Level 3):
(In thousands)
Contingent Consideration
Embedded Derivatives
Liabilities:
Balance at January 1, 2025
$— $— 
Additions
21,881 12,553 
Settlements
— (864)
Change in fair value
(861)144 
Balance at December 31, 2025
$21,020 $11,833